OROS methylphenidate

DRUG5 trials

Sponsors

Indiana University School of Medicine, Massachusetts General Hospital, University of Illinois at Chicago, Johnson & Johnson Taiwan Ltd, University of Utah

Conditions

ADHDAttention Deficit Disorder With HyperactivityAttention Deficit Hyperactivity Disorder

Phase 2

Quetiapine and Concerta in the Treatment for ADHD and Aggressive Behavior.

CompletedNCT00550147

Indiana University School of MedicineAttention Deficit Disorder With Hyperactivity

Start: 2004-02-29End: 2005-11-30Updated: 2015-05-13

OROS Methylphenidate (Concerta) in the Treatment of Adult ADHD

CompletedNCT02215538

University of UtahAttention Deficit Hyperactivity Disorder

Start: 2004-11-30End: 2006-06-30Updated: 2014-08-13

Phase 4

Proton Magnetic Spectroscopy in Children and Adolescents With ADHD Before and After Treatment With OROS Methylphenidate

CompletedNCT00593112

Massachusetts General HospitalADHD

Start: 2006-11-30End: 2009-05-31Updated: 2012-08-31

Basic and Clinical Research on Attention Deficit Hyperactivity Disorder (ADHD)

CompletedNCT00663442

University of Illinois at ChicagoADHD

Start: 1999-12-31End: 2004-11-30Updated: 2008-04-22

The Impact of Osmotic Release Oral Delivery System Methylphenidate (OROS MPH) Upon Family of Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)

CompletedNCT00758160

Johnson & Johnson Taiwan LtdAttention Deficit Disorder With Hyperactivity

Start: 2008-03-31End: 2008-06-30Updated: 2014-04-08